344 related articles for article (PubMed ID: 33986322)
21. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
22. Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.
Lim YS; Gwak GY; Choi J; Lee YS; Byun KS; Kim YJ; Yoo BC; Kwon SY; Lee HC
J Hepatol; 2019 Jul; 71(1):35-44. PubMed ID: 30876946
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.
Tseng CM; Chen TB; Hsu YC; Chang CY; Lin JT; Mo LR
Asia Pac J Clin Oncol; 2016 Dec; 12(4):421-429. PubMed ID: 27435683
[TBL] [Abstract][Full Text] [Related]
24. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting.
Idilman R; Gunsar F; Koruk M; Keskin O; Meral CE; Gulsen M; Elhan AH; Akarca US; Yurdaydin C
J Viral Hepat; 2015 May; 22(5):504-10. PubMed ID: 25431108
[TBL] [Abstract][Full Text] [Related]
25. Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
Zhang Y; Hu XY; Zhong S; Yang F; Zhou TY; Chen G; Wang YY; Luo JX
World J Gastroenterol; 2014 Apr; 20(16):4745-52. PubMed ID: 24782628
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir.
Jeon HJ; Jung SW; Park NH; Yang Y; Noh JH; Ahn JS; Kim HR; Lee JH; Shin JW
Clin Mol Hepatol; 2017 Sep; 23(3):230-238. PubMed ID: 28669175
[TBL] [Abstract][Full Text] [Related]
27. Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.
Rodríguez-Nóvoa S; García-Samaniego J; Prieto M; Calleja JL; Pascasio JM; Delgado Blanco M; Crespo J; Buti M; Bonet Vidal ML; Arenas Ruiz Tapiador J; Fernández-Rodríguez C; Solá R; Fraga E; González Diéguez L; Núñez O; Praga M; Del Pino-Montes J; Romero-Gómez M; Morillas R; Diago M; Castro Á;
J Clin Gastroenterol; 2016 Oct; 50(9):779-89. PubMed ID: 27332746
[TBL] [Abstract][Full Text] [Related]
28. Bone turnover and density in healthy women during breastfeeding and after weaning.
López JM; González G; Reyes V; Campino C; Díaz S
Osteoporos Int; 1996; 6(2):153-9. PubMed ID: 8704355
[TBL] [Abstract][Full Text] [Related]
29. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
Gur A; Dikici B; Nas K; Bosnak M; Haspolat K; Sarac AJ
BMC Gastroenterol; 2005 Sep; 5():30. PubMed ID: 16171525
[TBL] [Abstract][Full Text] [Related]
31. The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients.
Sasadeusz J; Audsley J; Mijch A; Baden R; Caro J; Hunter H; Matthews G; McMahon MA; Olender SA; Siliciano RF; Lewin SR; Thio CL
AIDS; 2008 May; 22(8):947-55. PubMed ID: 18453854
[TBL] [Abstract][Full Text] [Related]
32. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
Lai CL; Rosmawati M; Lao J; Van Vlierberghe H; Anderson FH; Thomas N; Dehertogh D
Gastroenterology; 2002 Dec; 123(6):1831-8. PubMed ID: 12454840
[TBL] [Abstract][Full Text] [Related]
33. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
[TBL] [Abstract][Full Text] [Related]
34. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
35. Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?
Gill US; Zissimopoulos A; Al-Shamma S; Burke K; McPhail MJ; Barr DA; Kallis YN; Marley RT; Kooner P; Foster GR; Kennedy PT
J Infect Dis; 2015 Feb; 211(3):374-82. PubMed ID: 25156561
[TBL] [Abstract][Full Text] [Related]
36. Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment.
Luo D; Liu Y; Chen R; Niu M; Liu L; Li X; Li Q; Huang B; Wang J; Xu D; Lin S
Antiviral Res; 2019 Oct; 170():104579. PubMed ID: 31398372
[TBL] [Abstract][Full Text] [Related]
37. Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection.
de Menezes EG; Machado AA; Barbosa F; de Paula FJ; Navarro AM
J Bone Miner Metab; 2017 Mar; 35(2):234-242. PubMed ID: 27026434
[TBL] [Abstract][Full Text] [Related]
38. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
39. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus.
Gerdhem P; Isaksson A; Akesson K; Obrant KJ
Osteoporos Int; 2005 Dec; 16(12):1506-12. PubMed ID: 15824889
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]